Cargando…
Bi‐allelic mutation in SEC16B alters collagen trafficking and increases ER stress
Osteogenesis imperfecta (OI) is a genetically and clinically heterogeneous disorder characterized by bone fragility and reduced bone mass generally caused by defects in type I collagen structure or defects in proteins interacting with collagen processing. We identified a homozygous missense mutation...
Autores principales: | El‐Gazzar, Ahmed, Voraberger, Barbara, Rauch, Frank, Mairhofer, Mario, Schmidt, Katy, Guillemyn, Brecht, Mitulović, Goran, Reiterer, Veronika, Haun, Margot, Mayr, Michaela M, Mayr, Johannes A, Kimeswenger, Susanne, Drews, Oliver, Saraff, Vrinda, Shaw, Nick, Fratzl‐Zelman, Nadja, Symoens, Sofie, Farhan, Hesso, Högler, Wolfgang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086588/ https://www.ncbi.nlm.nih.gov/pubmed/36916446 http://dx.doi.org/10.15252/emmm.202216834 |
Ejemplares similares
-
A novel cryptic splice site mutation in COL1A2 as a cause of osteogenesis imperfecta
por: El-Gazzar, Ahmed, et al.
Publicado: (2021) -
SMAD3 mutation in LDS3 causes bone fragility by impairing the TGF-β pathway and enhancing osteoclastogenesis
por: El-Gazzar, Ahmed, et al.
Publicado: (2022) -
Cardiac, bone and growth plate manifestations in hypocalcemic infants: revealing the hidden body of the vitamin D deficiency iceberg
por: Uday, Suma, et al.
Publicado: (2018) -
Investigating the role of ASCC1 in the causation of bone fragility
por: Voraberger, Barbara, et al.
Publicado: (2023) -
New Developments in the Treatment of X-Linked Hypophosphataemia: Implications for Clinical Management
por: Saraff, Vrinda, et al.
Publicado: (2020)